Baupost Group Discloses 35 Percent Stake In Idenix Pharmaceuticals - ValueWalk Premium

Baupost Group Discloses 35 Percent Stake In Idenix Pharmaceuticals

Baupost Group, the hedge fund founded and managed by Seth Klarman, disclosed ownership of 53,331,109 shares (a 35.38% stake) in Idenix Pharmaceuticals Inc (NASDAQ:IDIX) based on its 13D filing with the Securities and Exchange Commission (SEC), and as first reported by . . .

This content is exclusively for paying members of ValueWalk Premium

Gain Exclusive Access to the Insider Strategies and Letters to Shareholders from the Top Hedge Funds and Maximize Your Portfolio Growth with ValueWalk Premium

Get Started Now with a FREE 7-Day Trial

🔻

If you are a current ValueWalk Premium member and are having an account error please clear cache and cookies. If that does not work, email [email protected] or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk